跳至主要内容
临床试验/ACTRN12611000740998
ACTRN12611000740998已完成未知

Adults and the effect of A1 versus A2 milk consumption on gastrointestinal symptoms and systemic exposure to beta-casomorphin-7 (BCM7)

Curtin University of Technology0 个研究点目标入组 41 人开始时间: 2011年7月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Do not drink more than 1 serve milk/day
  • Those who report lactose intolerance but have not received medial diagnosis
  • Willing to consume milk for 8 weeks
  • Able to sign and understand informed consent

排除标准

  • Milk allergy
  • Diagnosed lactose intolerance
  • Pregnancy and lactation
  • Cardiovascular event in the last 6 months
  • Current, habitual opioid consumption
  • Antibiotic treatment within the last 8 weeks prior to screening
  • Immunosuppressive medications or anti-inflammatory drugs within the last 4 weeks prior to screening

研究者

发起方
Curtin University of Technology

相似试验